HBIO Reports $23.7M Q4 Revenue, 60% Gross Margin, +27% Adjusted EBITDA; Outlines Strategy for Translational Science Growth
Harvard Bioscience Inc · LABORATORY ANALYTICAL INSTRUMENTS · Now $6.40
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS